I Didn’t Want to Be the Kind of Doctor Who Looks Into a Patient’s Eyes and Says, “There Is Nothing We Can Do.”
Read our story: onepatientonecure.org/why-i-founde...
🗓 Nov 11 | 8–11 PM
📍 Sawtooth Kitchen, Hanover NH
For more detail email us at
📩 Rex@FlyingNarwhalEntertainment.com
🗓 Nov 11 | 8–11 PM
📍 Sawtooth Kitchen, Hanover NH
For more detail email us at
📩 Rex@FlyingNarwhalEntertainment.com
Whether you contributed, gave a shoutout, or just came by to show love, you helped us move closer to our mission.
#BostonEvents #CancerAwareness #OnePatientOneCure #HopeForCancerPatients
Whether you contributed, gave a shoutout, or just came by to show love, you helped us move closer to our mission.
#BostonEvents #CancerAwareness #OnePatientOneCure #HopeForCancerPatients
When innovations don’t leave the research paper, the people who need them most are left waiting.
So the point of a breakthrough?
It’s to reach someone.
To heal,
To help,
To change a life.
When innovations don’t leave the research paper, the people who need them most are left waiting.
So the point of a breakthrough?
It’s to reach someone.
To heal,
To help,
To change a life.
I Didn’t Want to Be the Kind of Doctor Who Looks Into a Patient’s Eyes and Says, “There Is Nothing We Can Do.”
Read our story: onepatientonecure.org/why-i-founde...
I Didn’t Want to Be the Kind of Doctor Who Looks Into a Patient’s Eyes and Says, “There Is Nothing We Can Do.”
Read our story: onepatientonecure.org/why-i-founde...
I Didn’t Want to Be the Kind of Doctor Who Looks Into a Patient’s Eyes and Says, “There Is Nothing We Can Do.”
Read our story: onepatientonecure.org/why-i-founde...
The collection has generated 73,000+ views.
Bridging discovery and translation in novel biomarkers and big data-based biomedical studies for cancer management.
#medsky #womeninstem
The collection has generated 73,000+ views.
Bridging discovery and translation in novel biomarkers and big data-based biomedical studies for cancer management.
#medsky #womeninstem
Manisha is a results-driven product leader with extensive experience in developing and launching AI-powered solutions within the global healthcare sector.
Manisha is a results-driven product leader with extensive experience in developing and launching AI-powered solutions within the global healthcare sector.
#Science #WomeninSTEM
onepatientonecure.org
#Science #WomeninSTEM
onepatientonecure.org
At OnePatientOneCure, confronting this complex global challenge is the driving force behind our non-profit mission.
onepatientonecure.org
At OnePatientOneCure, confronting this complex global challenge is the driving force behind our non-profit mission.
onepatientonecure.org
Jiawei Tang had 15 years of experience in the healthcare industry, with a focus on strategic planning, corporate operations, and international marketing.
She now serves as Co-Founder and Chief Operating Officer of Global Biopharma Partnerships.
Jiawei Tang had 15 years of experience in the healthcare industry, with a focus on strategic planning, corporate operations, and international marketing.
She now serves as Co-Founder and Chief Operating Officer of Global Biopharma Partnerships.
Karl Hess is a digital health innovator and healthcare strategist with 25+ years of experience and over $20B in deal-making.
Karl has shaped over 100 digital ventures across diagnostics, therapeutics, genomics, and virtual care.
Karl Hess is a digital health innovator and healthcare strategist with 25+ years of experience and over $20B in deal-making.
Karl has shaped over 100 digital ventures across diagnostics, therapeutics, genomics, and virtual care.
Abla Creasey is a distinguished leader in regenerative medicine with over 40 years of experience in therapeutic development, regulatory strategy, and collaborative partnerships.
Abla Creasey is a distinguished leader in regenerative medicine with over 40 years of experience in therapeutic development, regulatory strategy, and collaborative partnerships.
We are pleased to welcome Henry Hagopian to the Board of Directors at One Patient One Cure.
Henry brings a wealth of financial expertise shaped by more than 30 years in biotech, healthcare, and technology.
We are pleased to welcome Henry Hagopian to the Board of Directors at One Patient One Cure.
Henry brings a wealth of financial expertise shaped by more than 30 years in biotech, healthcare, and technology.
Deepa Kushwaha is a scientific researcher with extensive expertise in cancer biology and rare disease research.
A former research fellow at Dana-Farber Cancer Institute and Harvard Medical School.
Deepa Kushwaha is a scientific researcher with extensive expertise in cancer biology and rare disease research.
A former research fellow at Dana-Farber Cancer Institute and Harvard Medical School.
With over 30 years of clinical experience in Obstetrics and Gynecology and a thriving career as a medical writer and content strategist.
With over 30 years of clinical experience in Obstetrics and Gynecology and a thriving career as a medical writer and content strategist.
Anthony R. Franco brings more than Two Decades of Experience across Legal, Operational, and Biotech Sectors.
He currently serves as Chief Operating Officer and Co-Founder of ReST THERAPEUTICS US.
Anthony R. Franco brings more than Two Decades of Experience across Legal, Operational, and Biotech Sectors.
He currently serves as Chief Operating Officer and Co-Founder of ReST THERAPEUTICS US.
Humam will play an important role in shaping the technical direction and expanding the reach of our work at One Patient One Cure.
In his role as co-founder and interim technical officer of One Patient One Cure.
Humam will play an important role in shaping the technical direction and expanding the reach of our work at One Patient One Cure.
In his role as co-founder and interim technical officer of One Patient One Cure.
We are pleased to welcome Dr. Qingyu Luo, MD, PhD, as a co-founder & President of One Patient One Cure.
Dr. Luo brings a strong background in medicine and research, with a focus on cancer biology.
Welcome, Dr. Qingyu Luo.
We are pleased to welcome Dr. Qingyu Luo, MD, PhD, as a co-founder & President of One Patient One Cure.
Dr. Luo brings a strong background in medicine and research, with a focus on cancer biology.
Welcome, Dr. Qingyu Luo.
Currently serving as Assistant Professor of Research Physiology and Neuroscience at the Zilkha Neurogenetic Institute, Keck Medicine of USC,
Welcome to One Patient One Cure, Dr. Ruslan Rust!
Currently serving as Assistant Professor of Research Physiology and Neuroscience at the Zilkha Neurogenetic Institute, Keck Medicine of USC,
Welcome to One Patient One Cure, Dr. Ruslan Rust!